SAMANTHA PRZYBYLSKI: Open Payments
NPI 1245984673 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,058 in 106 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,569 · 2025 $3,058
Food & beverage: $2,208Consulting: $630Education: $219
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 16 | $1,094 |
| AstraZeneca Pharmaceuticals LP | 15 | $456 |
| Regeneron Healthcare Solutions, Inc. | 9 | $351 |
| Verona Pharma, Inc. | 9 | $192 |
| Electromed, Inc. | 26 | $169 |
| Merck Sharp & Dohme LLC | 4 | $98 |
| Grifols USA, LLC | 4 | $95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $93 |
| GlaxoSmithKline, LLC. | 4 | $84 |
| Amgen Inc. | 3 | $83 |
Products named: DUPIXENT, FASENRA, Ohtuvayre, SMARTVEST, WINREVAIR, Prolastin-C Liquid, AIRSUPRA, OFEV.
Industry payments across NV — which companies pay providers there.
